As of Jun 22
| +0.40 / +1.12%|
The 2 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 44.50, with a high estimate of 48.00 and a low estimate of 41.00. The median estimate represents a +22.76% increase from the last price of 36.25.
The current consensus among 4 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.